Institut Claudius Regaud
Clinical trials sponsored by Institut Claudius Regaud, explained in plain language.
-
New drug combo may boost prostate cancer surgery success
Disease control OngoingThis study tests whether adding the drug darolutamide before and after surgery helps men with high-risk or locally advanced prostate cancer. About 240 men will either have surgery alone or surgery plus the drug. The goal is to see if the drug delays the cancer from coming back or…
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Adaptive radiotherapy study for head and neck cancer withdrawn before starting
Knowledge-focused TerminatedThis study was designed to test whether automatic software could accurately outline tumors and healthy organs on daily CT scans during radiation therapy for head and neck cancer. The goal was to save time and improve precision compared to manual contouring. However, the study was…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC